Herein, we analyzed the mutation, amplification, copy number data, mRNA dysregulation, DNA methylation and the relevant clinical profiles to understand the molecular landscape and immunotherapeutic implications of the B7 and TNFR families in HCC. This evidence concerns the gene TNFRSF1A and hepatocellular carcinoma.